Table 1.
Features of current and upcoming BRSs.
| Device | Manufacturer | CE mark (year) | Backbone | Coating |
Strut Thickness (μm) |
Antiproliferative drug | Drug dose | Resorption time (months) | |
|---|---|---|---|---|---|---|---|---|---|
| Biodegradable polymer scaffold | Absorb BVS | Abbott vascular | 2012 | PLLA | PDLLA | 157 | Everolimus | 100 μg/mm2 | 24–48 |
| DESolve Nx | Elixir medical | 2014 | PLLA | Polylactide based polymer | 150 | Novolimus | 5 μg/mm | 24 | |
| DESolve Cx | Elixir medical | 2017 | PLLA | Polylactide based polymer | 120 | Novolimus | 5 μg/mm | 24 | |
| Fantom | REVA medical | 2017 | PTD-PC | PTD-PC | 125 | Sirolimus | 115 μg (3.0 ×18 mm) |
36 | |
| ART 18AZ | Arterial remodeling technology | 2015 | PDLLA | N/A | 170 | None | None | 6 | |
| Mirage | Manli cardiology | PLLA fibers | PLLA | 125 | Sirolimus | N/A | 14 | ||
| FAST | Boston scientific | PLLA | N/A | ≤99 | Everolimus | N/A | 12–24 | ||
| MeRes-100 | Meril life science | PLLA | PDLLA | 100 | Sirolimus | 1.25 μg/mm2 | 24 | ||
| FORTITUDE | Amaranth medical | PLLA | PDLLA | 150 | Sirolimus | 96 mg/cm2 | 12–24 | ||
| APTITUDE | Amaranth medical | PLLA | PDLLA | 120 | Sirolimus | 96 mg/cm2 | >36 | ||
| MAGNITUDE | Amaranth medical | PLLA | PDLLA | 98 | Sirolimus | 96 mg/cm2 | 24–36 | ||
| Xinsorb | HuaAn biotechnology | PLLA | PDLLA | 160 | Sirolimus | 12 μg/mm | 24–36 | ||
| Firesorb | MicroPort medical | PLLA | PDLLA | 100-125 | Sirolimus | 4 μg/mm | 36 | ||
| NeoVas | Lepu medical | PLLA | PDLLA | 170 | Sirolimus | 15.3 μg/mm | 36 | ||
| IDEAL biostent | Xenogenics | PAE salicylic acid | Adipic acid | 200 | Sirolimus | N/A | 6–9 | ||
| Bioabsorbable metal scaffold | DREAMS 1G | Biotronik | 2015 | Magnesium alloy | PLGA | 125 | Paclitaxel | 7.4 μg/cm2 | 9–12 |
| Magmaris (DREAMS 2G) | Biotronik | 2016 | Magnesium alloy | PLLA | 150 | Sirolimus | 140 mg/cm2 | 9–12 | |
| IBS | Life tech scientific | Iron alloy | PDLLA | 70 | Sirolimus | 235 μg/cm2 | 12–24 |
BVS, bioresorbable vascular scaffold; IBS, iron bioresorbable scaffold; N/A, not available; PDLLA, poly-d,l-lactide; PLLA, poly-l-lactide; PTD-PC=desaminotyrosine polycarbonate; PLGA, poly-lactic-co-glycolic acid.